泰林生物:2024年报净利润0.13亿 同比下降35%

Financial Performance - The basic earnings per share decreased by 33.33% from 0.1800 to 0.1200 yuan [1] - The net profit fell by 35% from 0.20 billion to 0.13 billion yuan [1] - The return on equity decreased by 36.18% from 3.04% to 1.94% [1] - Operating revenue increased by 29.26% from 2.7 billion to 3.49 billion yuan [1] - The net asset per share dropped to 0 from 5.33 yuan, marking a 100% decrease [1] - The undistributed profits per share decreased by 9.61% from 2.29 to 2.07 yuan [1] - The share capital reserve per share increased by 93.85% from 1.79 to 3.47 yuan [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 30.53 million shares, accounting for 40.15% of the circulating shares, with an increase of 6.09 million shares [1] - Notable new shareholders include Ni Weiju with 6.30 million shares (8.29%) and Zhang Yunfei with 0.57 million shares (0.74%) [2] - Several previous top shareholders have exited, including J.P. Morgan Securities PLC and UBS AG [2] Dividend Distribution - The company announced a dividend distribution of 1 yuan per share (including tax) [3]